Enhancing Trauma Treatment invites dr. Arne Hofmann
In recent years EMDR therapy research and clinical practice has made significant progress in the treatment of depressive patients. The webinar serves the purpose to communicate recent
findings so that clinicians can apply them in clinical practice. Two cornerstones of these new developments are a
series of randomized controlled studies that show the effectiveness of EMDR therapy in depression as well as an evidence based protocol for treatment of depressive patients with EMDR
therapy, the EMDR DeprEnd protocol. Both will be presented.
General learning objectives
After the webinar participants are able to:
1. Present the latest insights and developments in the field of depressive disorders and their treatment with EMDR.
2. Develop a treatment plan for individual patients with depression including the use of compensation zones.
3. Know and apply the six steps of the EMDR DeprEnd protocol.
4. Use the processing of episode triggers, belief systems and depressive states to improve the clinical situation of depressive patients.
In the last years EMDR therapy has been studied in its effectiveness for depressive disorders in nine randomized controlled studies and a number of meta-analyses. The results show
that EMDR therapy is at least as effective as cognitive behavioral therapy in the treatment of depression and after it recent meta-analysis may even increase the number of
complete remissions after treatment (Yan et
Meant for whom?
For therapists who have completed the EMDR Basic Training.
Dr. Arne Hofmann MD, is specialist for psychosomatic and internal medicine, founder of the EMDR-Institute Germany and one of the heads of an EMDR trauma hospital in
Wesseling Germany). He learned EMDR in 1991 from Francine Shapiro and is co-founding board member of EMDR Europe and a member of the German national guideline commission on the treatment of PTSD.
He is teaching, researching and publishing in the field of psychological trauma, depression and has been teaching at the Universities of Cologne, Boston University and Peking University. In 2010
he co-founded the
European EDEN research group that has up to now co-published 5 controlled studies that have shown that EMDR is highly effective in the treatment of depression. For his work has received several
awards and the Order of Merit of the Federal Republic of Germany.
Suzy Matthijssen, PhD, is a clinical psychologist-psychotherapist, senior researcher, supervisor in cognitive behavioral therapy and EMDR, psychotraumatherapist NtVP, NRGD
registered pro justice reporter, EFT therapist and she is a lecturer at university and postdoctorate psychology specialization programs. She is the vice president of the Dutch EMDR association.
The focus of the research she conducts is on the optimization of trauma treatments. She is the director of the Altrecht Academic Anxiety Centre where she is also head of an intensive trauma
treatment program. She is connected to Utrecht University.
Ad de Jongh, PhD, is clinical psychologist and professor of Anxiety and Behavior Disorders at the University of Amsterdam. Further, he is honorary professor in psychology at
the School of Health Sciences of Salford University in Manchester, at the Institute of Health and Society of the University of Worcester, and at the School of Psychology of Queen’s University
in Belfast. He is head of research of Psychotrauma Expertise Center (PSYTREC), approved trainer for the EMDR Europe association, an expert in the treatment of anxiety disorders.